ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $281,771 | -78.2% | 31,518 | -65.3% | 0.00% | -87.5% |
| Q3 2022 | $1,292,000 | -80.0% | 90,849 | -79.4% | 0.01% | -92.0% |
| Q2 2022 | $6,446,000 | -26.9% | 441,518 | 0.0% | 0.10% | -7.4% |
| Q1 2022 | $8,817,000 | -2.1% | 441,518 | -14.3% | 0.11% | +18.7% |
| Q4 2021 | $9,007,000 | +317.8% | 515,000 | +87.3% | 0.09% | +911.1% |
| Q3 2021 | $2,156,000 | -23.8% | 275,000 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $2,830,000 | -36.6% | 275,000 | -19.4% | 0.02% | -33.3% |
| Q1 2021 | $4,464,000 | – | 341,269 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |